Sesen Bio 8-K Shows FDA Granted Co. Request For Type C Meeting To Discuss Study Protocol For Added Phase 3 Trial Co. Will Conduct For Potential Resubmission Of Its Biologics License Application For Vicineum For Treatment Of Bladder Cancer